ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q1SCImago #4,475Hybrid

JAC-Antimicrobial Resistance

Abbreviation (ISO):JAC-ANTIMICROB RESIS
•
Identifier (ISSN):2632-1823(Print)
•
Publisher:Oxford University Press
Clarivate JCR Index Advisory: Name Changed (Not Indexed in Latest JCR)
Clarivate IF (2026)
3.9↑ +0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for JAC-Antimicrobial Resistance

WoS Q2
23453.420233.320253.92026
Annual Impact Factor Metric
Current (2026):3.9
Scopus SJR & RankScopus Q1
1.057
#4,475

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
36

36 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate5.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
124articles/year
99.82% Gold OA•87.9% Original Research

Aims & Scope

JAC-Antimicrobial Resistance (abbr: JAC-ANTIMICROB RESIS, ISSN: 2632-1823) is a peer-reviewed international scholarly journal in the field of Multiple, published by Oxford University Press. The periodical holds a Journal Impact Factor (JIF) of 3.90, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.057 (Q1), an H-index of 36.

Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

INFECTIOUS DISEASES

Q2
Rank37/141
IndexESCI
JCRESCI2026

MICROBIOLOGY

Q2
Rank71/167
IndexESCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q2
Rank113/356
IndexESCI
JCIESCI2026

INFECTIOUS DISEASES

Q2
Rank45/141
IndexESCI
JCIESCI2026

MICROBIOLOGY

Q2
Rank65/167
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q2
Rank102/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

3 year
2026Latest
IF3.9
Articles / Year—
Total Citations—
2025
IF3.3
Articles / Year—
Total Citations—
2023
IF3.4
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,475Scopus Q1SCImago Profile
Scopus Coverage:2019-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.057

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.60

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,286 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,860
3-Year Documents491
Citable Documents469

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate49.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ1
ImmunologyQ2
Immunology and AllergyQ2
MicrobiologyQ2
Microbiology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

JAC-Antimicrobial Resistance (abbr: JAC-ANTIMICROB RESIS, ISSN: 2632-1823) is a peer-reviewed international scholarly journal in the field of Multiple, published by Oxford University Press. The periodical holds a Journal Impact Factor (JIF) of 3.90, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.057 (Q1), an H-index of 36.

The journal enforces rigorous peer evaluation with an annual output of approximately 124 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,286 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Oxford University Press
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 44ff1251-12de-4b65-b5c5-a446ad7f6ddd
Database Updated: 2026-09-28